{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:23:06Z","timestamp":1784204586189,"version":"3.55.0"},"reference-count":0,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[1996,2,1]],"date-time":"1996-02-01T00:00:00Z","timestamp":823132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1996,2]]},"abstract":"<jats:p>We studied 122 stool samples collected from 25 patients with hematologic malignancies who received prophylactic norfloxacin. Fecal samples were obtained at admission and twice weekly thereafter during prophylaxis. Fluoroquinolone-resistant Escherichia coli strains were isolated from the feces of 10 (40%) of the patients; two patients had fluoroquinolone-resistant E. coli strains prior to beginning norfloxacin treatment, and in the other eight patients, the strains appeared subsequently. One patient developed fluoroquinolone-resistant E. coli bacteremia after 10 days of norfloxacin administration.<\/jats:p>","DOI":"10.1128\/aac.40.2.503","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:24:50Z","timestamp":1539044690000},"page":"503-505","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":69,"title":["Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis"],"prefix":"10.1128","volume":"40","author":[{"given":"J","family":"Carratala","sequence":"first","affiliation":[{"name":"Services of Infectious Diseases, University of Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fernandez-Sevilla","sequence":"additional","affiliation":[{"name":"Services of Infectious Diseases, University of Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Tubau","sequence":"additional","affiliation":[{"name":"Services of Infectious Diseases, University of Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Dominguez","sequence":"additional","affiliation":[{"name":"Services of Infectious Diseases, University of Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Gudiol","sequence":"additional","affiliation":[{"name":"Services of Infectious Diseases, University of Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.40.2.503","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.40.2.503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:05:45Z","timestamp":1645473945000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.40.2.503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,2]]}},"alternative-id":["10.1128\/AAC.40.2.503"],"URL":"https:\/\/doi.org\/10.1128\/aac.40.2.503","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,2]]},"assertion":[{"value":"1996-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}